A call for the United States to accelerate the implementation of reliever combination inhaled corticosteroid–formoterol inhalers in asthma

James G. Krings, Joe K. Gerald, Kathryn V. Blake, Jerry A. Krishnan, Helen K. Reddel, Leonard B. Bacharier, Anne E. Dixon, Kaharu Sumino, Lynn B. Gerald, Ross C. Brownson, Stephen D. Persell, Conrad J. Clemens, Katherine M. Hiller, Mario Castro, Fernando D. Martinez

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)390-405
Number of pages16
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume207
Issue number4
DOIs
Publication statusPublished - 15 Feb 2023
Externally publishedYes

Keywords

  • Beta-agonist use
  • Mild persistent asthma
  • Double-blind
  • Budesonide/formoterol maintenance
  • Budesonide-formoterol
  • Single inhaler
  • Clinical characteristics
  • Severe exacerbations
  • Health disparities
  • Therapy

Cite this